Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ahmad Nezhadisalami"'
Publikováno v:
Journal of Nephropathology, Vol 13, Iss 1, Pp e21435-e21435 (2024)
Introduction: Treatment of mild to moderate hypokalemia is a high potassium-containing diet and oral pharmaceutical potassium products. However, several medical centers in Iran use injectable dosage forms orally, which is not a confirmed method by re
Externí odkaz:
https://doaj.org/article/edc31d51a74441a890e9c5348644e614
Autor:
Azam Doustmohammadian, Ahmad Nezhadisalami, Fahimeh Safarnezhad Tameshke, Nima Motamed, Mansooreh Maadi, Mohammad Farahmand, Masoudreza Sohrabi, Cain C. T. Clark, Hossein Ajdarkosh, Amir Hossein Faraji, Mehdi Nikkhah, Elham Sobhrakhshankhah, Ramin Ebrahimi, Farhad Zamani
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
The current study aimed to evaluate the efficacy of sitagliptin vs. placebo in treating non-alcoholic fatty liver disease (NAFLD). In a triple-blind randomized clinical trial, we assigned 120 eligible subjects with NAFLD to receive daily dosing of 50
Externí odkaz:
https://doaj.org/article/4adc06b3ba8f4c8cabb796095b054b3c
Publikováno v:
BioMedicine, Vol 9, Iss 3, p 16 (2019)
BioMedicine
BioMedicine
Background: Designation of disease activity is serious for the management of systemic lupus erythematosus (SLE). Serum level of β2 microglobulin (β2M) may be associated with illness activity in SLE disease. Since the role of β2M for assessing of i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3daae4dd3bd7a1c644b5e0878b28b4bb
https://doi.org/10.1051/bmdcn/2019090316
https://doi.org/10.1051/bmdcn/2019090316